Molecular basis of hypohidrotic ectodermal dysplasia: an update.

PubWeight™: 0.88‹?›

🔗 View Article (PMID 26294279)

Published in J Appl Genet on August 21, 2015

Authors

Wieslaw H Trzeciak1, Ryszard Koczorowski2

Author Affiliations

1: Department of Biochemistry and Molecular Biology, Poznan University of Medical Sciences, 6, Swiecickiego St., 60-781, Poznan, Poland. trzeciak@ump.edu.pl.
2: Department of Gerostomatology, Poznan University of Medical Sciences, 6, Swiecickiego St., 60-781, Poznan, Poland.

Articles cited by this

Wnt/beta-catenin signaling in development and disease. Cell (2006) 30.09

A cytokine-responsive IkappaB kinase that activates the transcription factor NF-kappaB. Nature (1997) 11.31

Activation of the IkappaB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain. Cell (2000) 10.90

Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat Rev Mol Cell Biol (2007) 10.23

Ubiquitin signalling in the NF-kappaB pathway. Nat Cell Biol (2005) 8.06

TRAF6 is a signal transducer for interleukin-1. Nature (1996) 7.38

Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-kappaB. Nature (2003) 6.53

Complementation cloning of NEMO, a component of the IkappaB kinase complex essential for NF-kappaB activation. Cell (1998) 6.48

The tumour suppressor CYLD negatively regulates NF-kappaB signalling by deubiquitination. Nature (2003) 6.11

CYLD is a deubiquitinating enzyme that negatively regulates NF-kappaB activation by TNFR family members. Nature (2003) 6.00

X-linked anhidrotic (hypohidrotic) ectodermal dysplasia is caused by mutation in a novel transmembrane protein. Nat Genet (1996) 3.90

X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-kappaB signaling. Nat Genet (2001) 3.86

Ectodermal dysplasias: a clinical classification and a causal review. Am J Med Genet (1994) 3.09

Molecular principles of hair follicle induction and morphogenesis. Bioessays (2005) 3.08

Clinical aspects of X-linked hypohidrotic ectodermal dysplasia. Arch Dis Child (1987) 2.95

E2 interaction and dimerization in the crystal structure of TRAF6. Nat Struct Mol Biol (2009) 2.79

Insights into Wnt binding and signalling from the structures of two Frizzled cysteine-rich domains. Nature (2001) 2.67

The IKK complex, a central regulator of NF-kappaB activation. Cold Spring Harb Perspect Biol (2010) 2.64

Involvement of a novel Tnf receptor homologue in hair follicle induction. Nat Genet (1999) 2.54

An updated overview on Wnt signaling pathways: a prelude for more. Circ Res (2010) 2.40

Mutations in the human homologue of mouse dl cause autosomal recessive and dominant hypohidrotic ectodermal dysplasia. Nat Genet (1999) 2.29

NF-kappaB is essential for induction of CYLD, the negative regulator of NF-kappaB: evidence for a novel inducible autoregulatory feedback pathway. J Biol Chem (2004) 1.97

Gene defect in ectodermal dysplasia implicates a death domain adapter in development. Nature (2002) 1.95

Two-amino acid molecular switch in an epithelial morphogen that regulates binding to two distinct receptors. Science (2000) 1.95

Molecular aspects of hypohidrotic ectodermal dysplasia. Am J Med Genet A (2009) 1.94

A hypermorphic IkappaBalpha mutation is associated with autosomal dominant anhidrotic ectodermal dysplasia and T cell immunodeficiency. J Clin Invest (2003) 1.92

Mutation in WNT10A is associated with an autosomal recessive ectodermal dysplasia: the odonto-onycho-dermal dysplasia. Am J Hum Genet (2007) 1.82

The Tabby phenotype is caused by mutation in a mouse homologue of the EDA gene that reveals novel mouse and human exons and encodes a protein (ectodysplasin-A) with collagenous domains. Proc Natl Acad Sci U S A (1997) 1.77

Permanent correction of an inherited ectodermal dysplasia with recombinant EDA. Nat Med (2003) 1.75

Regulation of hair follicle development by the TNF signal ectodysplasin and its receptor Edar. Development (2002) 1.70

Requirement of NF-kappaB/Rel for the development of hair follicles and other epidermal appendices. Development (2001) 1.69

The tumor suppressor cylindromatosis (CYLD) acts as a negative regulator for toll-like receptor 2 signaling via negative cross-talk with TRAF6 AND TRAF7. J Biol Chem (2005) 1.68

Ectodermal dysplasias: a new clinical-genetic classification. J Med Genet (2001) 1.58

Identification of a new splice form of the EDA1 gene permits detection of nearly all X-linked hypohidrotic ectodermal dysplasia mutations. Am J Hum Genet (1998) 1.51

The LDL receptor-related protein (LRP) family: an old family of proteins with new physiological functions. Ann Med (2007) 1.49

Ectodysplasin signaling in development. Cytokine Growth Factor Rev (2003) 1.48

Genetic basis of tooth agenesis. J Exp Zool B Mol Dev Evol (2009) 1.46

EDA2R is associated with androgenetic alopecia. J Invest Dermatol (2008) 1.44

Investigation of the male pattern baldness major genetic susceptibility loci AR/EDA2R and 20p11 in female pattern hair loss. Br J Dermatol (2012) 1.44

Dental agenesis: genetic and clinical perspectives. J Oral Pathol Med (2008) 1.44

Only four genes (EDA1, EDAR, EDARADD, and WNT10A) account for 90% of hypohidrotic/anhidrotic ectodermal dysplasia cases. Hum Mutat (2011) 1.42

Interleukin-1 receptor-associated kinase (IRAK) -1-mediated NF-kappaB activation requires cytosolic and nuclear activity. FASEB J (2008) 1.39

The transcription factors c-rel and RelA control epidermal development and homeostasis in embryonic and adult skin via distinct mechanisms. Mol Cell Biol (2004) 1.39

The ectodermal dysplasia receptor activates the nuclear factor-kappaB, JNK, and cell death pathways and binds to ectodysplasin A. J Biol Chem (2000) 1.38

Mutations in EDAR account for one-quarter of non-ED1-related hypohidrotic ectodermal dysplasia. Hum Mutat (2006) 1.37

Mutations in WNT10A are present in more than half of isolated hypodontia cases. J Med Genet (2012) 1.37

The NF-kappaB signalling pathway in human diseases: from incontinentia pigmenti to ectodermal dysplasias and immune-deficiency syndromes. Hum Mol Genet (2002) 1.36

Cloning of Tabby, the murine homolog of the human EDA gene: evidence for a membrane-associated protein with a short collagenous domain. Hum Mol Genet (1997) 1.35

Ectodysplasin is a collagenous trimeric type II membrane protein with a tumor necrosis factor-like domain and co-localizes with cytoskeletal structures at lateral and apical surfaces of cells. Hum Mol Genet (1999) 1.29

TRAF6-deficient mice display hypohidrotic ectodermal dysplasia. Proc Natl Acad Sci U S A (2002) 1.25

Significant correction of disease after postnatal administration of recombinant ectodysplasin A in canine X-linked ectodermal dysplasia. Am J Hum Genet (2007) 1.20

The anhidrotic ectodermal dysplasia gene (EDA) undergoes alternative splicing and encodes ectodysplasin-A with deletion mutations in collagenous repeats. Hum Mol Genet (1998) 1.18

Mutations within a furin consensus sequence block proteolytic release of ectodysplasin-A and cause X-linked hypohidrotic ectodermal dysplasia. Proc Natl Acad Sci U S A (2001) 1.15

Identification of a novel death domain-containing adaptor molecule for ectodysplasin-A receptor that is mutated in crinkled mice. Curr Biol (2002) 1.14

Ectodysplasin is released by proteolytic shedding and binds to the EDAR protein. Hum Mol Genet (2001) 1.13

Definitive evidence for an autosomal recessive form of hypohidrotic ectodermal dysplasia clinically indistinguishable from the more common X-linked disorder. Am J Hum Genet (1997) 1.13

Molecular basis of non-syndromic tooth agenesis: mutations of MSX1 and PAX9 reflect their role in patterning human dentition. Eur J Oral Sci (2003) 1.11

The trimerization domain of NEMO is composed of the interacting C-terminal CC2 and LZ coiled-coil subdomains. J Biol Chem (2004) 1.11

A replication study confirmed the EDAR gene to be a major contributor to population differentiation regarding head hair thickness in Asia. Hum Genet (2008) 1.06

Molecular basis for the unique specificity of TRAF6. Adv Exp Med Biol (2007) 1.06

WNT10A missense mutation associated with a complete odonto-onycho-dermal dysplasia syndrome. Eur J Hum Genet (2009) 1.05

Genes affecting tooth morphogenesis. Orthod Craniofac Res (2007) 1.05

Edar and Troy signalling pathways act redundantly to regulate initiation of hair follicle development. Hum Mol Genet (2008) 1.05

CYLD mutations in familial skin appendage tumours. J Med Genet (2008) 1.04

The Edar subfamily in feather placode formation. Dev Biol (2007) 1.04

Ocular symptoms and signs in patients with ectodermal dysplasia syndromes. Graefes Arch Clin Exp Ophthalmol (2004) 1.03

Myodegeneration in EDA-A2 transgenic mice is prevented by XEDAR deficiency. Mol Cell Biol (2004) 1.03

X-linked ectodermal dysplasia in the dog. J Hered (1998) 1.02

Signaling and subcellular localization of the TNF receptor Edar. Exp Cell Res (2001) 1.01

The EDA gene is a target of, but does not regulate Wnt signaling. Gene (2002) 1.01

X-linked anhidrotic ectodermal dysplasia disruption yields a mouse model for ocular surface disease and resultant blindness. Am J Pathol (2005) 0.99

Candidate gene analysis of tooth agenesis identifies novel mutations in six genes and suggests significant role for WNT and EDA signaling and allele combinations. PLoS One (2013) 0.99

Clinical findings in mosaic carriers of hypohidrotic ectodermal dysplasia. Arch Dermatol (2000) 0.96

EDAR mutation in autosomal dominant hypohidrotic ectodermal dysplasia in two Swedish families. BMC Med Genet (2006) 0.95

Autosomal dominant anhidrotic ectodermal dysplasias at the EDARADD locus. Hum Mutat (2007) 0.95

TAB2, TRAF6 and TAK1 are involved in NF-kappaB activation induced by the TNF-receptor, Edar and its adaptator Edaradd. Hum Mol Genet (2005) 0.94

Role of TRAF3 and -6 in the activation of the NF-kappa B and JNK pathways by X-linked ectodermal dysplasia receptor. J Biol Chem (2002) 0.93

Recent advances in understanding of the molecular basis of anhidrotic ectodermal dysplasia: discovery of a ligand, ectodysplasin A and its two receptors. J Appl Genet (2002) 0.91

Early respiratory and ocular involvement in X-linked hypohidrotic ectodermal dysplasia. Eur J Pediatr (2013) 0.89

Msx1 mutations: how do they cause tooth agenesis? J Dent Res (2011) 0.87

Mutation screening of the Ectodysplasin-A receptor gene EDAR in hypohidrotic ectodermal dysplasia. Eur J Hum Genet (2008) 0.86

PAX9 and MSX1 transcription factor genes in non-syndromic dental agenesis. Arch Oral Biol (2010) 0.85

Functional studies for the TRAF6 mutation associated with hypohidrotic ectodermal dysplasia. Br J Dermatol (2012) 0.84

A rare case of hypohidrotic ectodermal dysplasia caused by compound heterozygous mutations in the EDAR gene. J Invest Dermatol (2004) 0.83

The Gene Network Underlying Hypodontia. J Dent Res (2015) 0.83

Mutations in the EDA gene in three unrelated families reveal no apparent correlation between phenotype and genotype in the patients with an X-linked anhidrotic ectodermal dysplasia. Am J Med Genet (2001) 0.82

A rare heterozygous TRAF6 variant is associated with hypohidrotic ectodermal dysplasia. Br J Dermatol (2012) 0.82

A new mutation resulting in the truncation of the TRAF6-interacting domain of XEDAR: a possible novel cause of hypohidrotic ectodermal dysplasia. J Med Genet (2012) 0.80

Novel mutations in the EDAR gene in two Pakistani consanguineous families with autosomal recessive hypohidrotic ectodermal dysplasia. Br J Dermatol (2005) 0.80

Mutations in EDARADD account for a small proportion of hypohidrotic ectodermal dysplasia cases. Br J Dermatol (2010) 0.80

Induction of apoptosis by X-linked ectodermal dysplasia receptor via a caspase 8-dependent mechanism. J Biol Chem (2004) 0.80

Unusual presentation of a severe autosomal recessive anhydrotic ectodermal dysplasia with a novel mutation in the EDAR gene. Am J Med Genet A (2008) 0.80

Mosaic expression of hypohidrotic ectodermal dysplasia in an isolated affected female child. Arch Dermatol (1994) 0.80

Involvement of and interaction between WNT10A and EDA mutations in tooth agenesis cases in the Chinese population. PLoS One (2013) 0.78

Mutational analysis of TRAF6 reveals a conserved functional role of the RING dimerization interface and a potentially necessary but insufficient role of RING-dependent TRAF6 polyubiquitination towards NF-κB activation. Cell Signal (2010) 0.77